| Income Statement |
| Total Revenue | 3.01M |
|
| Revenues (USD) | 3.01M |
| Cost of Revenue | 1.59M |
| Gross Profit | 1.42M |
| Operating Expenses | 4.40M |
| Research and Development Expense | 1.18M |
| Selling, General and Administrative Expense | 2.27M |
| Operating Income | -2.98M |
| Net Income | -2.94M |
| Net Income Common Stock | -2.94M |
| Net Income Common Stock (USD) | -2.94M |
| Consolidated Income | -2.94M |
| Earnings per Basic Share | -0.20 |
| Earnings per Basic Share (USD) | -0.20 |
| Earnings per Diluted Share | -0.20 |
| Earning Before Interest & Taxes (EBIT) | -2.94M |
| Earning Before Interest & Taxes (USD) | -2.94M |
| Weighted Average Shares | 14.81M |
| Weighted Average Shares Diluted | 14.81M |
| Balance Sheet |
| Cash and Equivalents | 2.03M |
| Cash and Equivalents (USD) | 2.03M |
| Trade and Non-Trade Receivables | 2.01M |
| Current Assets | 6.64M |
| Property, Plant & Equipment Net | 2.51M |
| Total Assets | 9.23M |
| Current Liabilities | 5.51M |
| Total Liabilities | 5.51M |
| Accumulated Retained Earnings (Deficit) | -61.98M |
| Shareholders Equity | 3.73M |
| Shareholders Equity (USD) | 3.73M |
| Assets Non-Current | 2.59M |
| Deferred Revenue | 410.00K |
| Inventory | 2.07M |
| Trade and Non-Trade Payables | 1.44M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 306.00K |
| Net Cash Flow from Financing | 108.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.36M |
| Capital Expenditure | -454.00K |
| Issuance (Purchase) of Equity Shares | 108.00K |
| Net Cash Flow from Investing | -454.00K |
| Net Cash Flow from Operations | -3.02M |